Contemporary Unplanned Readmission Trends Following Management of Type B Aortic Dissection

다국어 초록 (Multilingual Abstract)

Purpose: Large studies have demonstrated improved survival outcomes with thoracic endovascular aortic repair (TEVAR) at two and five years compared to medical therapy; however, early TEVAR for acute type B aortic dissection (TBAD) remains controversial. We aimed to evaluate trends and clinical predictors of hospital readmissions in patients undergoing medical management and TEVAR for acute TBADs.
Materials and Methods: The Nationwide Readmissions Database was queried for all 30-day and 90-day index readmissions (30D-IR and 90D-IR, respectively) after a diagnosis of a TBAD from January 2012 to September 2015. Data on readmission diagnosis, patient demographics, and hospital characteristics were collected from readmitted patients and analyzed. Multivariable logistic regression models were used to identify the predictors of readmission after TEVAR or medical medical management of TBAD.
Results: We identified 53,117 patients with acute TBAD. Medical management was the initial treatment modality in 46,985 (88.4%) patients, while 6,132 (11.5%) underwent TEVAR. Factors including older patient age, lower household income, severity of comorbidities, initial hospital length of stay, and urgent procedure demonstrated an increased likelihood of experiencing 30D-IR and 90D-IR (P<0.05).
The rate of unplanned readmission for patients undergoing medical management remained stable (11.3% vs. 10.0% for 30D-IR; 19.1% vs. 15.5% for 90D-IR). Reasons for unplanned readmission in the TEVAR cohort were largely related to technical complications. There was no significant difference in readmission costs between medical management and TEVAR.
Conclusion: Number of unplanned readmissions in the TEVAR arm decreased significantly over time, whereas the number of readmissions for medical management remained stable.

참고문헌 (Reference)

1 Estrera AL, "Update on outcomes of acute type B aortic dissection" 83 : S842-S845, 2007

2 Nauta FJ, "Update in the management of type B aortic dissection" 21 : 251-263, 2016

3 Mody PS, "Trends in aortic dissection hospitalizations, interventions, and outcomes among medicare beneficiaries in the United States, 2000-2011" 7 : 920-928, 2014

4 Durham CA, "The natural history of medically managed acute type B aortic dissection" 61 : 1192-1198, 2015

5 Booher AM, "The IRAD classification system for characterizing survival after aortic dissection" 126 : 730.e19-730.e24, 2013

6 Kwolek CJ, "The INvestigation of STEnt grafts in aortic dissection(INSTEAD)trial : the need for ongoing analysis" 120 : 2513-2514, 2009

7 Fattori R, "Survival after endovascular therapy in patients with type B aortic dissection : a report from the International Registry of Acute Aortic Dissection(IRAD)" 6 : 876-882, 2013

8 DeBakey ME, "Surgical management of dissecting aneurysms of the aorta" 49 : 130-149, 1965

9 Eggebrecht H, "Resistant hypertension in patients with chronic aortic dissection" 19 : 227-231, 2005

10 Carroll BJ, "Readmissions after acute type B aortic dissection" 72 : 73-83.e2, 2020

11 Nienaber CA, "Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement" 340 : 1539-1545, 1999

12 Daily PO, "Management of acute aortic dissections" 10 : 237-247, 1970

13 Iannuzzi JC, "Favorable impact of thoracic endovascular aortic repair on survival of patients with acute uncomplicated type B aortic dissection" 68 : 1649-1655, 2018

14 Nienaber CA, "Endovascular repair of type B aortic dissection : long-term results of the randomized investigation of stent grafts in aortic dissection trial" 6 : 407-416, 2013

15 Averill R, "Development of the all patient refined DRGs (APR-DRGs)" 3M HIS 8-97,

16 Kret MR, "Compliance with long-term surveillance recommendations following endovascular aneurysm repair or type B aortic dissection" 58 : 25-31, 2013

17 van Walraven C, "A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data" 47 : 626-633, 2009